Client LoginSend a Press Release
CourierPR

Desks

779 releases · Page 9

Health & Medicine

Latest press releases filed to this category.

TriCelX, Inc ·

TriCelX Receives FDA Approval for XytriX ALS Study

FRISCO, TX, UNITED STATES -- TriCelX, Inc., a clinical-stage allogeneic biotherapeutics company based in Frisco, Texas, has received clearance from the U.S. Food and Drug Administration to proceed with its Phase 1/2 study of XytriX™ in …

DreaMed Diabetes Ltd ·

DreaMed Receives FDA Clearance for MODI, Bringing Automated Insulin Dose Recommendations to People with Type 2 Diabetes Using Injections

DreaMed Diabetes Ltd., a global leader in personalized diabetes treatment optimization, has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to MODI, a medical app that uses continuous glucose monitoring (CGM) and insulin data to …

INSTYTUTUM ·

INSTYTUTUM Reduces Skin Biological Age by Three Years in 84 Days

NEW YORK -- Swiss longevity skincare brand INSTYTUTUM has announced the results of a new independent clinical-instrumental study that demonstrates a three-year reduction in calculated skin biological age after just 84 days of use of the …

Society for Vascular Surgery ·

Rural Areas Face Critical Shortage of Vascular Surgeons

ROSEMONT, Ill. -- More than 75 million people in the United States live in a county without a vascular surgeon, according to new data released today by the American College of Surgeons (ACS). The findings reveal …

U.S. Career Institute ·

U.S. Career Institute Adds Virtual Clinical Skills Lab to Online Medical Assistant Program

FORT COLLINS, CO, UNITED STATES -- FORT COLLINS, CO, UNITED STATES, September 28, 2026 /CourierPR/ -- U.S. Career Institute, a leading distance education provider, has expanded its online Medical Assistant program to include a new Virtual Clinical Skills Lab, an optional educational experience that pairs online …

SkinCure Oncology ·

GentleCure Treats 150,000 Patients Without Surgery

BURR RIDGE, Ill. -- SkinCure Oncology, the industry leader in providing a comprehensive model for the delivery of Image-Guided Superficial Radiation Therapy (Image-Guided SRT) for the treatment of nonmelanoma skin cancer (NMSC), today reported that over …

Piedmont Healthcare ·

Piedmont Healthcare GME Programs Earn Accreditation

ATLANTA -- Piedmont Healthcare has received accreditation for three new Graduate Medical Education (GME) programs, marking a significant milestone in its efforts to expand physician training and strengthen healthcare access across Georgia. The newly accredited programs …

Oncolytics Biotech Inc ·

Oncolytics Biotech Inc. Accelerates REO 033 Enrollment for Pelareorep Study

SAN DIEGO -- Oncolytics Biotech Inc. has reported significant progress in its clinical trial REO 033, which is evaluating pelareorep, an investigational immunotherapy, in second-line RAS-mutant, microsatellite-stable metastatic colorectal cancer (mCRC). The company has activated nearly …

Goldenrod Therapeutics ·

Goldenrod Study Evaluates Alzheimer's Drug Candidate

HOUSTON -- Goldenrod Therapeutics and the Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases at the University of Texas Health Science Center are collaborating on a research project to evaluate an investigational small molecule 11h in …

Parachute ·

Canada Honors Top Crossing Guards in Annual Contest

TORONTO -- The annual Canada’s Favourite Crossing Guard contest, launched in 2005 to acknowledge the tremendous efforts of crossing guards who help keep children safe, has once again garnered significant attention. Since 2022, the contest has …

Silexion Therapeutics ·

Silexion Therapeutics Reports Positive Preclinical Findings for SIL204

Grand Cayman, Cayman Islands -- Silexion Therapeutics, a clinical-stage biotechnology company, has announced positive findings from its ongoing translational research program. The study, which is part of the company's Phase 2/3 clinical development, demonstrates that its …

Achieve Life Sciences, Inc ·

Achieve Life Sciences to Present Cytisinicline Data at CHEST 2026

SEATTLE and VANCOUVER, British Columbia -- SEATTLE and VANCOUVER, British Columbia, Sept. 28, 2026 /CourierPR/ -- Achieve Life Sciences, Inc., a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment for nicotine dependence, announced today that new data evaluating …

Polaris Market Research & Consulting, Inc ·

AI in Medical Imaging Market to Surge to USD 28.91B by 2034

The global Artificial Intelligence (AI) in Medical Imaging market is poised for significant growth, with a projected value of USD 28.91 billion by 2034, marking a compound annual growth rate (CAGR) of 35.3% over the forecast period. This expansion is …

Daré Bioscience Secures New Patent for DARE-HPV Treatment

SAN DIEGO -- Daré Bioscience has announced the issuance of a new U.S. patent that strengthens its intellectual property foundation for DARE-HPV, a potential first-in-category treatment for persistent high-risk HPV infection. The patent covers pharmaceutical compositions …

ALX Oncology Holdings Inc ·

ALX Oncology Validates Evorpacept in Gastric Cancer Clinical Trial

SOUTH SAN FRANCISCO, Calif. -- ALX Oncology, a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients’ lives, has announced the publication of clinical data from its ASPEN-06 randomized …

Children's Hospital of Philadelphia ·

Pediatric Health Chat Initiative Celebrates First Year

PHILADELPHIA -- This month, Children's Hospital of Philadelphia (CHOP) marked the first anniversary of its groundbreaking Pediatric Health Chat initiative, an online platform designed to combat pediatric health misinformation and provide families with accurate, evidence-based information …

Keros Therapeutics, Inc ·

Keros Therapeutics Starts Phase 2 Trial for DMD Treatment

LEXINGTON, Mass. -- Keros Therapeutics, a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders linked to dysfunctional signaling of the transforming growth factor-beta ("TGF-ß") family …

Allarity Therapeutics ·

Allarity Therapeutics Expands Lab Capabilities for Cancer Research

Allarity Therapeutics, a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib (2X-121), a differentiated, dual PARP and WNT pathway inhibitor, has announced the expansion of its in-house medical laboratory to include proteomics and cell line research capabilities. The move …

Project HEAL ·

Project HEAL Launches Virtual HEAL Week Events

NEW YORK -- Project HEAL, the only national nonprofit dedicated to removing systemic, healthcare, and financial barriers to eating disorder treatment, is set to host HEAL Week 2026, a campaign designed to bring together clinicians, researchers, …

Lantheus Holdings, Inc. (UNKNOWN) ·

Lantheus Starts Phase 2/3 Trial for Prostate Cancer Imaging Drug

BEDFORD, Mass. -- Lantheus Holdings, Inc., the leading radiopharmaceutical-focused company dedicated to enabling clinicians to find, fight, and follow disease to deliver better patient outcomes, today announced the first patient has been dosed in SPARROW NCT07831824, …

Xilio Therapeutics, Inc ·

Xilio Appoints Houvras as Chief Medical Officer

WALTHAM, Mass. -- Xilio Therapeutics, a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology therapies for people living with cancer, today announced the appointment of Yariv J. Houvras, M.D., Ph.D., as Chief Medical Officer.

Biohaven Ltd ·

Biohaven Oral Presentation Highlights FGFR3 ADC Progress

NEW HAVEN, Conn. -- The findings from the ongoing BHV1530-101 study will be featured in an oral presentation at the 38th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (ENA 2026), a leading international forum for …

LIT Wellness Solutions ·

LIT Wellness Solutions Earns Exceptional Care Award in West Chester

WEST CHESTER TOWNSHIP, OH, UNITED STATES -- WEST CHESTER TOWNSHIP, OH, UNITED STATES, September 28, 2026 /CourierPR/ -- LIT Wellness Solutions, a nutrition and wellness practice based in West Chester, Ohio, has earned the Exceptional Care Award from the Consumer Ratings Institute. The recognition, based on strong …

New Age Medical ·

Avesi Partners Invests in New Age Medical for Growth

STAMFORD, Conn. -- A leading MedTech hub serving the spinal surgery market, New Age Medical has announced a strategic investment from Avesi Partners, a firm with over $2.2 billion in assets under management. The partnership will …

Pharmazz, Inc ·

Pharmazz Completes Phase 4 Study for Sovateltide in Acute Ischemic Stroke

WILLOWBROOK, Ill. -- Pharmazz, Inc., a biopharmaceutical company focused on developing novel therapeutics for critical care and neurovascular conditions, has completed enrollment in a 160-patient Phase 4 clinical study of sovateltide (Tycamzzi®) for the treatment of …

Eton Pharmaceuticals ·

Eton Launches IMPAVIDO Capsules in US

DEER PARK, Ill. -- Eton Pharmaceuticals, an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced the launch of IMPAVIDO® (miltefosine) capsules in the United States. The company now holds exclusive …

GPN Vaccines, Inc ·

GPN Vaccines Present at Global Vaccine Conferences

NEW YORK -- GPN Vaccines, Inc., a clinical-stage biotechnology company developing a new generation of broadly protective bacterial vaccines designed to overcome the limitations of serotype-specific vaccination, announced today that it will present progress across its …

MediciNova, Inc ·

MediciNova Reports Positive MN-001 Trial Results for Diabetes and Liver Health

LA JOLLA, Calif. -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced the topline results from MN-001-NATG-202, …

Healthcare AI Automation Inc. dba Sayvant ·

Sayvant Named Quarterfinalist in Digital Health Awards

SAN FRANCISCO, CA, UNITED STATES -- SAN FRANCISCO, CA, UNITED STATES, September 28, 2026 /CourierPR/ -- Sayvant, the clinical documentation quality platform built by acute care physicians, has been named a Quarterfinalist in the 2026 Digital Health & AI Awards in the Rising Star, Transformative Care …

JJP Biologics ·

JJP Biologics to Present Data on Nebaprubart for Linear IgA Dermatosis at Conferences

JJP Biologics, a clinical-stage biotech firm focused on precision antibodies to correct immune pathway imbalances, will present interim data from its Phase Ib proof-of-concept trial of nebaprubart at two key scientific conferences in September 2026. The data, which positions nebaprubart …

Handtevy ·

Florida Expands Handtevy Mobile for Statewide Emergency Care

FT. LAUDERDALE, Fla. -- Florida is expanding its partnership with Handtevy to make its mobile emergency care platform, Handtevy Mobile, available statewide to hospital emergency departments and EMS agencies. This expansion builds on the program's success …

Loba Wellness ·

Clare Crawley Joins Loba Wellness as Strategic Advisor and Women’s Health Advocate

SAN FRANCISCO, CA, UNITED STATES -- SAN FRANCISCO, CA, UNITED STATES, September 27, 2026 /CourierPR/ -- Loba Wellness, a new women-focused health and wellness platform, has announced the addition of Clare Crawley as its Strategic Advisor and Women’s Health Advocate. This move comes as the company …

Mureva Phototherapy Inc ·

Mureva Phototherapy and Siemens Healthineers Expand Access to FDA-authorized Oral Mucositis Treatment

BRECKSVILLE, Ohio -- Mureva Phototherapy and Siemens Healthineers have entered into a co-marketing agreement to expand access to Mureva, the first FDA-authorized intraoral device for radiation-induced oral mucositis (OM). This collaboration aims to bring a practical …

Benivita Inc ·

Millions of Latino Families in Texas Struggle to Afford Healthcare

While America celebrates Hispanic Heritage Month, a stark reality looms large in Texas: millions of Latino families cannot afford to see a doctor. According to new federal data, nearly 24.6 percent of Hispanic adults in the United States lack health …

ProCure Proton Therapy Center ·

Prostate Cancer Specialist Chooses Proton Therapy at ProCure

SOMERSET, N.J. -- ProCure Proton Therapy Center, the first proton therapy facility in the tri-state region, has highlighted a unique patient story during National Prostate Cancer Awareness Month. Dr. Edward Soffen, a radiation oncologist with over …

SELLAS Life Sciences Group, Inc ·

SLS009 Shows Promising Activity in Combating Pancreatic Cancer Resistance

NEW YORK -- SELLAS Life Sciences Group, Inc. has announced preclinical data from studies evaluating SLS009, its highly selective cyclin-dependent kinases 9 (CDK9) inhibitor, in patient-derived organoid models of pancreatic ductal adenocarcinoma (PDAC). The findings were …

Enloe Health ·

CIRM Awards $9 Million to Enloe Health for Cell and Gene Therapy Center

San Diego, Calif. -- The California Institute for Regenerative Medicine (CIRM) has awarded $9 million to Enloe Health in Chico, California, to establish a Community Care Center of Excellence (CCCE) that will bring advanced cell and …

Nanexa ·

Nanexa and Novo Nordisk Enter Global Collaboration Agreement

UPPSALA, Sweden -- Nanexa AB, a Swedish drug delivery platform company specializing in long-acting injectable drugs based on its proprietary PharmaShell® technology platform, has entered into a global exclusive license and collaboration agreement with Novo Nordisk, …

Omotesando Helene Clinic ·

Omotesando Helene Clinic and Maison Privé Clinic Form Medical Partnership

TOKYO -- Omotesando Helene Clinic and Maison Privé Clinic have entered into a strategic partnership aimed at enhancing international medical exchange and patient support. The agreement, formalized through a Memorandum of Understanding (MOU), will see the …

C4 Therapeutics ·

C4 Therapeutics Presents New Data on Cemsidomide in Multiple Myeloma Trials

WATERTOWN, Mass. -- C4 Therapeutics, Inc. (C4T) presented new biomarker data from its Phase 1 clinical trial of cemsidomide in combination with dexamethasone at the 23rd International Myeloma Society (IMS) Annual Meeting. The data demonstrated robust …

Talk to the desk

Questions before you file?

Volume pricing, corrections, partnerships — whatever doesn't fit a form field. Tell us what you need and we'll size it properly.

Contact us